Ra Capital Management, L.P. Rocket Pharmaceuticals, Inc. Transaction History

Ra Capital Management, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$15.79 - $22.6 $20.1 Million - $28.8 Million	-1,275,374 Reduced 52.98%	1,131,775 $19.4 Million
Q4 2022 Feb 14, 2023	BUY	$15.5 - $22.76 $4.65 Million - $6.83 Million	300,000 Added 14.24%	2,407,149 $47.1 Million
Q1 2021 May 17, 2021	SELL	$43.34 - $65.91 $1.25 Million - $1.91 Million	-28,932 Reduced 1.35%	2,107,149 $93.5 Million
Q4 2020 Feb 16, 2021	BUY	$23.3 - $59.57 $49.8 Million - $127 Million	2,136,081 New	2,136,081 $117 Million

209

93.2M

319K

70.3K

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $1.02B
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

Get notified when there are updates to the investment portfolio of Ra Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Ra Capital Management, L.P. with notifications on news.